OmniAb (OABI) Assets (2021 - 2026)
OmniAb's (OABI) quarterly Assets came in at $293.6 million in Q1 2026, down 4.09% year-on-year from $306.2 million in Q1 2025, and down 2.41% on a QoQ basis from $300.9 million in Q4 2025.
OmniAb (OABI) Assets (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Assets data on file, last reported at $293.6 million in Q1 2026.
- On a quarterly basis, Assets fell 4.09% year-over-year to $293.6 million in Q1 2026; TTM through Mar 2026 was $293.6 million, a 4.09% decrease from a year earlier, with the FY2025 full-year figure at $300.9 million, down 7.57% from the prior year.
- Assets for Q1 2026 stood at $293.6 million, down from $300.9 million in the prior quarter.
- Over the last five years, Assets for OABI reached as high as $421.2 million in Q4 2022 and fell as low as $236.8 million in Q2 2022.
- Historically, Assets has averaged $327.7 million across 5 years, with a median of $325.6 million in 2024.
- Across the five-year window, Assets jumped 37283.13% in 2022 and declined 16.77% in 2024, its largest moves.
- Year by year, Assets stood at $421.2 million in 2022, then dropped by 10.92% to $375.2 million in 2023, then decreased by 13.24% to $325.6 million in 2024, then decreased by 7.57% to $300.9 million in 2025, then fell by 2.41% to $293.6 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $293.6 million in Q1 2026, $300.9 million in Q4 2025, and $309.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 293.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293.65 Mn |
| Dec 31, 2025 | 300.91 Mn |
| Sep 30, 2025 | 309.69 Mn |
| Jun 30, 2025 | 295.67 Mn |
| Mar 31, 2025 | 306.18 Mn |
| Dec 31, 2024 | 325.56 Mn |
| Sep 30, 2024 | 331.55 Mn |
| Jun 30, 2024 | 337.26 Mn |
| Mar 31, 2024 | 352.56 Mn |
| Dec 31, 2023 | 375.23 Mn |
| Sep 30, 2023 | 391.71 Mn |
| Jun 30, 2023 | 405.24 Mn |
| Mar 31, 2023 | 413.04 Mn |
| Dec 31, 2022 | 421.21 Mn |
| Sep 30, 2022 | 237.61 Mn |
| Jun 30, 2022 | 236.79 Mn |
| Mar 31, 2022 | 236.90 Mn |
| Dec 31, 2021 | 304.47 Mn |
| Sep 30, 2021 | 236.99 Mn |
| Jun 30, 2021 | 633,415.00 |